Search results for "Infectious Diseases"
COVID-19 rebound occurs with or without antivirals, doesn't affect outcomes, studies find
Rebound of both COVID-19 symptoms and viral load was rare in untreated, unvaccinated outpatients, one study showed, while another found similar rates of viral rebound in patients treated with nirmatrelvir-ritonavir, molnupiravir, or neither antiviral.
https://immattersacp.org/weekly/archives/2023/02/21/2.htm
21 Feb 2023
Studies look at COVID-19 vaccine boosters; ACP, Annals forum tackles challenging clinical questions
Two Israeli studies showed that vaccine boosters reduced rates of infection and severe disease. Experts gathered for the seventh ACP and Annals of Internal Medicine virtual forum on COVID-19. The FDA authorized a monoclonal antibody for pre-exposure prophylaxis in certain patients.
https://immattersacp.org/weekly/archives/2021/12/14/1.htm
14 Dec 2021
Telemedicine's time has arrived
As the need for remote health care expands, medical educators and residents continue to refine the best ways to teach and learn telemedicine.
https://immattersacp.org/archives/2022/09/telemedicines-time-has-arrived.htm
1 Sep 2022
Latest COVID-19 guidelines come out against bamlanivimab, remdesivir
The NIH and the Infectious Diseases Society of America found insufficient data to support bamlanivimab, while the World Health Organization said the same about remdesivir. The FDA issued more emergency use authorizations, and research looked at racial and other disparities in COVID-19 outcomes.
https://immattersacp.org/weekly/archives/2020/11/24/1.htm
24 Nov 2020
Prepare for next pandemic by training leaders
In response to the COVID-19 pandemic and the prospect of others, public health and medical groups are developing training initiatives to increase the numbers of infectious disease and public health specialists across the country.
https://immattersacp.org/archives/2023/03/prepare-for-next-pandemic-by-training-leaders.htm
1 Mar 2023
ATS/IDSA release clinical practice guideline on diagnosing, treating CAP
The new American Thoracic Society (ATS) and Infectious Diseases Society of America (IDSA) guideline updates the 2007 community-acquired pneumonia (CAP) guideline, and changes include a different perspective on macrolides.
https://immattersacp.org/weekly/archives/2019/10/08/4.htm
8 Oct 2019
Latest research looks at prolonged symptoms, drug treatments in COVID-19
Two studies found symptoms to be common months to a year after COVID-19 infection, while other research found benefits from interleukin-6 inhibitors but no significant effects of ivermectin, remdesivir, and hydroxychloroquine.
https://immattersacp.org/weekly/archives/2021/07/13/1.htm
13 Jul 2021
New reports on early symptoms, cardiac complications of COVID-19
Loss of smell and taste have been suggested as possible early symptoms of COVID-19, and cardiac complications appear to be a significant issue among infected patients with or without baseline cardiovascular disease.
https://immattersacp.org/weekly/archives/2020/03/31/2.htm
31 Mar 2020
IDSA updates treatment guidelines, while studies identify symptoms in specific age groups
The Infectious Diseases Society of America (IDSA) changed its recommendations on steroids, remdesivir, and other therapies. New research from Europe quantified COVID-19 symptoms in older adults as well as neurological complications.
https://immattersacp.org/weekly/archives/2020/06/30/1.htm
30 Jun 2020
DEI or DIE?
The College has become a leader in the world of justice, equity, diversity, and inclusion. While it is tempting to feel a sense of accomplishment, there is a gnawing feeling that more needs to be done.
https://immattersacp.org/archives/2021/05/dei-or-die.htm
1 May 2021